Follow
Dhiraj Kumar, PhD
Dhiraj Kumar, PhD
Columbia University Irving Medical Center, New York, USA
Verified email at cumc.columbia.edu
Title
Cited by
Cited by
Year
Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
DKGCK Ramesh Butti, Sumit Das, Vinoth Prasanna Gunasekaran, Amit Singh Yadav
Molecular Cancer 17 (34), 2018
3042018
MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2
A Ghosh, D Dasgupta, A Ghosh, S Roychoudhury, D Kumar, M Gorain, ...
Cell death & disease 8 (3), e2706-e2706, 2017
1552017
Osteopontin as a therapeutic target for cancer
M Bandopadhyay, A Bulbule, R Butti, G Chakraborty, P Ghorpade, ...
Expert opinion on therapeutic targets 18 (8), 883-895, 2014
1442014
Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
X Dai, KS Ahn, LZ Wang, C Kim, A Deivasigamni, F Arfuso, JY Um, ...
Molecular Cancer Therapeutics 15 (12), 2966-2976, 2016
862016
Osteopontin: a potentially important therapeutic target in cancer
M Ahmed, R Behera, G Chakraborty, S Jain, V Kumar, P Sharma, ...
Expert opinion on therapeutic targets 15 (9), 1113-1126, 2011
862011
Andrographolide Inhibits Osteopontin Expression and Breast Tumor Growth Through Down Regulation of PI3 Kinase/Akt Signaling Pathway
S Kumar, H S. Patil, P Sharma, D Kumar, S Dasari, V G. Puranik, ...
Current Molecular Medicine 16 (8), 952-966, 2012
842012
Non-coding RNAs as potential therapeutic targets in breast cancer
D Tomar, AS Yadav, D Kumar, G Bhadauriya, GC Kundu
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1863 (4), 194378, 2020
772020
Notch1-MAPK signaling axis regulates CD133+ cancer stem cell-mediated melanoma growth and angiogenesis
D Kumar, S Kumar, M Gorain, D Tomar, HS Patil, NNV Radharani, ...
Journal of Investigative Dermatology 136 (12), 2462-2474, 2016
752016
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
D Kumar, M Gorain, G Kundu, GC Kundu
Molecular cancer 16, 1-18, 2017
682017
Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway
D Kumar, S Haldar, M Gorain, S Kumar, FA Mulani, AS Yadav, L Miele, ...
BMC cancer 18, 1-17, 2018
622018
Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway
NNV Radharani, AS Yadav, R Nimma, TVS Kumar, A Bulbule, ...
Cancer cell international 22 (1), 122, 2022
602022
The biology and therapeutic implications of tumor dormancy and reactivation
AS Yadav, PR Pandey, R Butti, NNV Radharani, S Roy, SR Bhalara, ...
Frontiers in oncology 8, 72, 2018
572018
Functional characterization of stromal osteopontin in melanoma progression and metastasis
S Kumar, P Sharma, D Kumar, G Chakraborty, M Gorain, GC Kundu
PloS one 8 (7), e69116, 2013
552013
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma
N Jain, K Hartert, S Tadros, W Fiskus, O Havranek, MCJ Ma, A Bouska, ...
Science translational medicine 11 (497), eaav5599, 2019
542019
RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics
PR Pandey, KH Young, D Kumar, N Jain
Molecular cancer 21 (1), 58, 2022
422022
Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression
R Butti, R Nimma, G Kundu, A Bulbule, TVS Kumar, VP Gunasekaran, ...
Oncogene 40 (11), 2002-2017, 2021
372021
Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis
H Han, Y Wang, J Curto, S Gurrapu, S Laudato, A Rumandla, ...
Cell reports 39 (1), 2022
282022
The potential of class 3 semaphorins as both targets and therapeutics in cancer
R Mishra, D Kumar, D Tomar, G Chakraborty, S Kumar, GC Kundu
Expert Opinion on Therapeutic Targets 19 (3), 427-442, 2015
182015
Noncoding RNAs: biology and applications—a Keystone Symposia report
J Cable, E Heard, T Hirose, KV Prasanth, LL Chen, JE Henninger, ...
Annals of the new York Academy of Sciences 1506 (1), 118-141, 2021
142021
One-pot fluorescent labeling protocol for complex hydroxylated bioactive natural products
S Haldar, S Kumar, SP Kolet, HS Patil, D Kumar, GC Kundu, ...
The Journal of Organic Chemistry 78 (20), 10192-10202, 2013
122013
The system can't perform the operation now. Try again later.
Articles 1–20